Clinical trial
A Prospective Comparison of Low Dose Hydroxychloroquine and Phlebotomy in the Treatment of Porphyria Cutanea Tarda. IRB 02-435
NCT01573754 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Comparison of Low Dose Hydroxychloroquine and Phlebotomy in the Treatment of Porphyria Cutanea Tarda. IRB 02-435
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 21, 2006
- Completion date
- July 6, 2021
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.